VEGFC Human, Sf9

Vascular Endothelial Growth Factor C Human Recombinant, Sf9
Cat. No.
BT8705
Source
Sf9, Baculovirus cells.
Synonyms
Vascular Endothelial Growth Factor C, Vascular Endothelial Growth Factor-Related Protein, Flt4-L, VRP, FLT4 Ligand DHM, Flt4 Ligand, LMPH1D, VEGF-C, Vascular endothelial growth factor C, VEGF-C, Flt4 ligand, Flt4-L, Vascular endothelial growth factor-related protein.
Appearance
Sterile filtered colorless solution.
Purity
Greater than 90.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

VEGFC Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 125 amino acids (112-227a.a.) and having a molecular mass of 14.2kDa (Molecular size on SDS-PAGE will appear at approximately 18-28kDa).
VEGFC is expressed with a 6 amino acid His tag at C-Terminus and purified by proprietary chromatographic techniques.

Product Specs

Introduction
VEGF-C, also referred to as Vascular Endothelial Growth Factor Related Protein (VRP), is a recently identified member of the VEGF growth factor family. It exhibits the closest resemblance to VEGF-D. The human VEGF-C cDNA sequence encodes a precursor protein comprising 416 amino acids. This protein demonstrates a high degree of similarity to its mouse counterpart. Analogous to VEGF-D, VEGF-C possesses a VEGF homology domain located within the central third of the precursor molecule, flanked by extended N- and C-terminal regions. In adult tissues, VEGF-C exhibits elevated expression levels in the heart, placenta, ovary, and small intestine. Recombinant human VEGF-C, engineered to lack the N- and C-terminal extensions while retaining the central VEGF homology domain, predominantly assembles into non-covalently associated dimers. Functionally, this protein serves as a ligand for both VEGFR-2/KDR and VEGFR-3/FLT-4. Given the abundant expression of VEGFR-3 on lymphatic endothelial cells, it has been proposed that VEGF-C plays a role in the regulation of lymphatic endothelium growth and/or differentiation. While recombinant human VEGF-C also exhibits mitogenic activity towards vascular endothelial cells, its potency in this regard is significantly lower compared to VEGF-A.
Description
Recombinant Human VEGFC, produced in Sf9 Baculovirus cells, is a single, glycosylated polypeptide chain comprising 125 amino acids (spanning positions 112 to 227). It has a molecular mass of 14.2 kDa. On SDS-PAGE, the apparent molecular size will appear between 18-28 kDa due to glycosylation. This protein is engineered with a 6-amino acid His tag located at the C-terminus and is purified using proprietary chromatographic techniques.
Physical Appearance
A clear and colorless solution that has been sterilized by filtration.
Formulation
The VEGFC protein solution is provided at a concentration of 0.5 mg/ml and is formulated in a buffer consisting of Phosphate Buffered Saline (pH 7.4) and 20% glycerol.
Stability
For short-term storage (up to 4 weeks), the product can be stored at 4°C. For extended storage, it is recommended to store the product in frozen aliquots at -20°C. To further enhance stability during long-term storage, the addition of a carrier protein such as HSA or BSA (0.1%) is advised. Repeated freeze-thaw cycles should be avoided to maintain protein integrity.
Purity
The purity of the protein is determined to be greater than 90% using SDS-PAGE analysis.
Synonyms
Vascular Endothelial Growth Factor C, Vascular Endothelial Growth Factor-Related Protein, Flt4-L, VRP, FLT4 Ligand DHM, Flt4 Ligand, LMPH1D, VEGF-C, Vascular endothelial growth factor C, VEGF-C, Flt4 ligand, Flt4-L, Vascular endothelial growth factor-related protein.
Source
Sf9, Baculovirus cells.
Amino Acid Sequence
ADPAHYNTEI LKSIDNEWRK TQCMPREVCI DVGKEFGVAT NTFFKPPCVS VYRCGGCCNS EGLQCMNTST SYLSKTLFEI TVPLSQGPKP VTISFANHTS CRCMSKLDVY RQVHSIIRRH HHHHH.

Product Science Overview

Introduction

Vascular Endothelial Growth Factor C (VEGF-C) is a member of the VEGF family, which plays a crucial role in angiogenesis and lymphangiogenesis. VEGF-C is particularly significant for its ability to promote the growth of lymphatic vessels. It acts primarily on lymphatic endothelial cells (LECs) through its receptor VEGFR-3, promoting their survival, growth, and migration .

Structure and Expression

Human VEGF-C cDNA encodes a pre-pro-protein consisting of 416 amino acid residues. The protein is highly homologous to its mouse counterpart. VEGF-C contains a VEGF homology domain in the middle third of the precursor molecule, flanked by long N- and C-terminal extensions . In adults, VEGF-C is highly expressed in the heart, placenta, ovary, and small intestine .

Recombinant VEGF-C (Sf9)

Recombinant VEGF-C is produced using the Sf9 insect cell expression system. This recombinant form lacks the N- and C-terminal extensions and includes only the middle VEGF homology domain. It forms primarily non-covalently linked dimers .

The recombinant VEGF-C produced in Sf9 cells is a single, glycosylated polypeptide chain containing 125 amino acids (112-227a.a.) and has a molecular mass of approximately 14.2 kDa. It is expressed with a 6 amino acid His-tag at the C-terminal end and purified using proprietary chromatographic techniques .

Biological Activity

VEGF-C is a ligand for both VEGFR-2/KDR and VEGFR-3/FLT-4 receptors. VEGFR-3 is strongly expressed in lymphatic endothelial cells, suggesting that VEGF-C is involved in the regulation of lymphatic endothelium growth and differentiation . Although VEGF-C is also a mitogen for vascular endothelial cells, it is less potent than VEGF-A .

Applications and Stability

Recombinant VEGF-C is used primarily for laboratory research purposes. It is supplied as a sterile filtered, lyophilized (freeze-dried) powder or as a colorless solution. The lyophilized form should be reconstituted in sterile water and can be further diluted in aqueous solutions .

The stability of VEGF-C is maintained at room temperature for up to three weeks in its lyophilized form. Upon reconstitution, it should be stored at 4°C for 2-7 days and for longer periods below -18°C to prevent freeze-thaw cycles .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.